|
IL118631A
(en)
|
1995-06-27 |
2002-05-23 |
Tanabe Seiyaku Co |
History of pyridazinone and processes for their preparation
|
|
WO2004022540A2
(en)
*
|
2002-09-06 |
2004-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridazinone and pyridone derivatives as adenosine antagonists
|
|
US7378423B2
(en)
|
2004-06-11 |
2008-05-27 |
Japan Tobacco Inc. |
Pyrimidine compound and medical use thereof
|
|
EA015127B1
(ru)
*
|
2006-06-08 |
2011-06-30 |
Эли Лилли Энд Компани |
Антагонисты мсн-рецепторов
|
|
WO2009054952A2
(en)
|
2007-10-22 |
2009-04-30 |
Angion Biomedica Corp. |
Small molecule inhibitors of parp activity
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
ES2625945T3
(es)
|
2012-11-14 |
2017-07-21 |
Glaxosmithkline Llc |
Tieno[3,2-c]piridin-4(5H)-onas como inhibidores de bet
|
|
US9266891B2
(en)
|
2012-11-16 |
2016-02-23 |
Boehringer Ingelheim International Gmbh |
Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors
|
|
EP2961747B1
(en)
|
2013-02-27 |
2017-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
US9050346B2
(en)
|
2013-03-11 |
2015-06-09 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
UY35395A
(es)
|
2013-03-12 |
2014-10-31 |
Abbvie Inc |
Inhibidores de bromodominios tetracíclicos
|
|
HUE043568T2
(hu)
|
2013-03-14 |
2019-08-28 |
Glaxosmithkline Ip No 2 Ltd |
2,3-diszubsztituált 1-acil-4-amino-1,2,3,4-tetrahidrokinolin származékok és bromodomén inhibitorokkénti felhasználásuk
|
|
US9670221B2
(en)
|
2013-03-14 |
2017-06-06 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Furopyridines as bromodomain inhibitors
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
WO2014206150A1
(en)
|
2013-06-28 |
2014-12-31 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
SG10201804471PA
(en)
*
|
2013-10-18 |
2018-07-30 |
Celgene Quanticel Research Inc |
Bromodomain inhibitors
|
|
RU2720237C2
(ru)
|
2013-11-18 |
2020-04-28 |
Форма Терапеутикс, Инк. |
Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
|
|
CN110627770A
(zh)
|
2013-11-18 |
2019-12-31 |
福马疗法公司 |
作为bet溴域抑制剂的四氢喹啉组成物
|
|
WO2015099107A1
(ja)
|
2013-12-26 |
2015-07-02 |
塩野義製薬株式会社 |
含窒素６員環誘導体およびそれらを含有する医薬組成物
|
|
HUE041546T2
(hu)
|
2014-01-09 |
2019-05-28 |
Orion Corp |
Biciklusos heterociklusos származékvegyületek mint bromo doméninhibitorok
|
|
WO2015131005A1
(en)
|
2014-02-28 |
2015-09-03 |
The Regents Of The University Of Michigan |
9h-pyrimido[4,5-b]indoles and related analogs as bet bromodomain inhibitors
|
|
PL3134403T3
(pl)
|
2014-04-23 |
2020-07-13 |
Incyte Corporation |
1H-pirolo[2,3-c]pirydyn-7(6H)-ony i pirazolo[3,4-c]pirydyn-7(6H)-ony jako inhibitory białek BET
|
|
BR112017004580A2
(pt)
|
2014-09-12 |
2018-01-23 |
GlaxoSmithKline Intellectual Property |
composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento.
|
|
WO2016092375A1
(en)
|
2014-12-11 |
2016-06-16 |
Zenith Epigenetics Corp. |
Substituted heterocycles as bromodomain inhibitors
|
|
EP3262045A1
(en)
|
2015-02-27 |
2018-01-03 |
The Regents of The University of Michigan |
9h-pyrimido [4,5-b]indoles as bet bromodomain inhibitors
|
|
AR104259A1
(es)
|
2015-04-15 |
2017-07-05 |
Celgene Quanticel Res Inc |
Inhibidores de bromodominio
|
|
JP2018527293A
(ja)
|
2015-06-16 |
2018-09-20 |
オリオン コーポレーション |
ブロモドメイン阻害剤としてのスピロ［シクロブタン−１，３’−インドリン］−２’−オン誘導体
|
|
ES2913048T3
(es)
|
2015-09-21 |
2022-05-31 |
Opna Immuno Oncology Sa |
Compuestos heterocíclicos y usos de estos
|
|
CA2998545A1
(en)
|
2015-09-22 |
2017-03-30 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyridinone dicarboxamide for use as bromodomain inhibitors
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
WO2017103670A1
(en)
|
2015-12-14 |
2017-06-22 |
Zenith Epigenetics Lid. |
1h-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridinyl heterocyclic bet bromodomain inhibitors
|
|
PT3442972T
(pt)
|
2016-04-15 |
2020-05-29 |
Abbvie Inc |
Inibidores de bromodomínio
|
|
EP3445750A4
(en)
|
2016-04-18 |
2019-11-27 |
Celgene Quanticel Research, Inc. |
THERAPEUTIC COMPOUNDS
|
|
WO2017197056A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
WO2017223452A1
(en)
|
2016-06-23 |
2017-12-28 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bromodomain-containing protein 9 (brd9) by conjugation of brd9 inhibitors with e3 ligase ligand and methods of use
|
|
CN108069958A
(zh)
|
2016-11-10 |
2018-05-25 |
凯惠科技发展(上海)有限公司 |
一种含氮杂环类化合物、其制备方法、药物组合物及应用
|
|
CN110167939B
(zh)
*
|
2017-01-11 |
2021-12-31 |
江苏豪森药业集团有限公司 |
吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用
|
|
JP7840635B2
(ja)
|
2017-12-20 |
2026-04-06 |
貝達薬業股▲ふん▼有限公司 |
ブロモドメインタンパク質阻害剤である化合物、および組成物
|
|
US11427593B2
(en)
|
2018-01-16 |
2022-08-30 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Bromodomain inhibitor compound and use thereof
|
|
CN110041253B
(zh)
|
2018-01-17 |
2022-03-29 |
上海翰森生物医药科技有限公司 |
吡啶类n-氧化衍生物及其制备方法和应用
|
|
EP3828183A4
(en)
*
|
2018-07-25 |
2022-03-09 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
SULFOXIMINE COMPOUND AS BROMO-DOMAIN INHIBITOR AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF
|
|
CN110964012B
(zh)
|
2018-09-29 |
2021-08-13 |
上海凌达生物医药有限公司 |
一类稠杂环联芳基苄醇类化合物、制备方法和用途
|
|
US11192900B2
(en)
|
2018-10-30 |
2021-12-07 |
Nuvation Bio Inc. |
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
|
|
US20230065463A1
(en)
|
2019-01-29 |
2023-03-02 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
WO2020187123A1
(zh)
|
2019-03-17 |
2020-09-24 |
上海凌达生物医药有限公司 |
一类吡咯酰胺并吡啶酮类化合物、制备方法和用途
|
|
WO2020253711A1
(zh)
|
2019-06-17 |
2020-12-24 |
中国科学院上海药物研究所 |
一种吡咯并吡啶酮类化合物、其制备方法、其组合物和用途
|
|
KR102677015B1
(ko)
*
|
2019-07-02 |
2024-06-19 |
누베이션 바이오 인크. |
Bet 억제제로서의 헤테로시클릭 화합물
|
|
WO2021222466A1
(en)
|
2020-04-29 |
2021-11-04 |
Nuvation Bio Inc. |
Heterocyclic compounds as bet inhibitors
|